Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

290 related articles for article (PubMed ID: 27144436)

  • 1. Nuclear receptor 4A1 (NR4A1) as a drug target for treating rhabdomyosarcoma (RMS).
    Lacey A; Hedrick E; Li X; Patel K; Doddapaneni R; Singh M; Safe S
    Oncotarget; 2016 May; 7(21):31257-69. PubMed ID: 27144436
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Nuclear Receptor 4A1 (NR4A1) as a Drug Target for Renal Cell Adenocarcinoma.
    Hedrick E; Lee SO; Kim G; Abdelrahim M; Jin UH; Safe S; Abudayyeh A
    PLoS One; 2015; 10(6):e0128308. PubMed ID: 26035713
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Nuclear receptor 4A1 as a drug target for breast cancer chemotherapy.
    Hedrick E; Lee SO; Doddapaneni R; Singh M; Safe S
    Endocr Relat Cancer; 2015 Oct; 22(5):831-40. PubMed ID: 26229035
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Potent inhibition of breast cancer by bis-indole-derived nuclear receptor 4A1 (NR4A1) antagonists.
    Hedrick E; Li X; Cheng Y; Lacey A; Mohankumar K; Zarei M; Safe S
    Breast Cancer Res Treat; 2019 Aug; 177(1):29-40. PubMed ID: 31119568
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Inhibition of NR4A1 Promotes ROS Accumulation and IL24-Dependent Growth Arrest in Rhabdomyosarcoma.
    Hedrick E; Mohankumar K; Lacey A; Safe S
    Mol Cancer Res; 2019 Nov; 17(11):2221-2232. PubMed ID: 31462501
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The nuclear orphan receptor NR4A1 regulates β1-integrin expression in pancreatic and colon cancer cells and can be targeted by NR4A1 antagonists.
    Hedrick E; Lee SO; Safe S
    Mol Carcinog; 2017 Sep; 56(9):2066-2075. PubMed ID: 28418095
    [TBL] [Abstract][Full Text] [Related]  

  • 7. NR4A1 Antagonists Inhibit β1-Integrin-Dependent Breast Cancer Cell Migration.
    Hedrick E; Lee SO; Doddapaneni R; Singh M; Safe S
    Mol Cell Biol; 2016 May; 36(9):1383-94. PubMed ID: 26929200
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Bis-Indole-Derived Nuclear Receptor 4A1 (NR4A1, Nur77) Ligands as Inhibitors of Endometriosis.
    Mohankumar K; Li X; Sung N; Cho YJ; Han SJ; Safe S
    Endocrinology; 2020 Apr; 161(4):. PubMed ID: 32099996
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Targeting NR4A1 (TR3) in cancer cells and tumors.
    Lee SO; Li X; Khan S; Safe S
    Expert Opin Ther Targets; 2011 Feb; 15(2):195-206. PubMed ID: 21204731
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The orphan nuclear receptor NR4A1 (Nur77) regulates oxidative and endoplasmic reticulum stress in pancreatic cancer cells.
    Lee SO; Jin UH; Kang JH; Kim SB; Guthrie AS; Sreevalsan S; Lee JS; Safe S
    Mol Cancer Res; 2014 Apr; 12(4):527-538. PubMed ID: 24515801
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Diindolylmethane analogs bind NR4A1 and are NR4A1 antagonists in colon cancer cells.
    Lee SO; Li X; Hedrick E; Jin UH; Tjalkens RB; Backos DS; Li L; Zhang Y; Wu Q; Safe S
    Mol Endocrinol; 2014 Oct; 28(10):1729-39. PubMed ID: 25099012
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Nuclear receptor 4A1 (NR4A1) antagonists induce ROS-dependent inhibition of mTOR signaling in endometrial cancer.
    Mohankumar K; Li X; Sridharan S; Karki K; Safe S
    Gynecol Oncol; 2019 Jul; 154(1):218-227. PubMed ID: 31053403
    [TBL] [Abstract][Full Text] [Related]  

  • 13. PAX3-FOXO1A Expression in Rhabdomyosarcoma Is Driven by the Targetable Nuclear Receptor NR4A1.
    Lacey A; Rodrigues-Hoffman A; Safe S
    Cancer Res; 2017 Feb; 77(3):732-741. PubMed ID: 27864345
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Bis-Indole-Derived NR4A1 Ligands and Metformin Exhibit NR4A1-Dependent Glucose Metabolism and Uptake in C2C12 Cells.
    Mohankumar K; Lee J; Wu CS; Sun Y; Safe S
    Endocrinology; 2018 May; 159(5):1950-1963. PubMed ID: 29635345
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Flavonoids kaempferol and quercetin are nuclear receptor 4A1 (NR4A1, Nur77) ligands and inhibit rhabdomyosarcoma cell and tumor growth.
    Shrestha R; Mohankumar K; Martin G; Hailemariam A; Lee SO; Jin UH; Burghardt R; Safe S
    J Exp Clin Cancer Res; 2021 Dec; 40(1):392. PubMed ID: 34906197
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Inactivation of the orphan nuclear receptor TR3/Nur77 inhibits pancreatic cancer cell and tumor growth.
    Lee SO; Abdelrahim M; Yoon K; Chintharlapalli S; Papineni S; Kim K; Wang H; Safe S
    Cancer Res; 2010 Sep; 70(17):6824-36. PubMed ID: 20660371
    [TBL] [Abstract][Full Text] [Related]  

  • 17. New Drug Candidate Targeting the 4A1 Orphan Nuclear Receptor for Medullary Thyroid Cancer Therapy.
    Zhang L; Liu W; Wang Q; Li Q; Wang H; Wang J; Teng T; Chen M; Ji A; Li Y
    Molecules; 2018 Mar; 23(3):. PubMed ID: 29498706
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Bis-Indole Derivatives as Dual Nuclear Receptor 4A1 (NR4A1) and NR4A2 Ligands.
    Upadhyay S; Hailemariam AE; Mariyam F; Hafiz Z; Martin G; Kothari J; Farkas E; Sivaram G; Bell L; Tjalkens R; Safe S
    Biomolecules; 2024 Feb; 14(3):. PubMed ID: 38540704
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The Histone Methyltransferase Gene G9A Is Regulated by Nuclear Receptor 4A1 in Alveolar Rhabdomyosarcoma Cells.
    Shrestha R; Mohankumar K; Jin UH; Martin G; Safe S
    Mol Cancer Ther; 2021 Mar; 20(3):612-622. PubMed ID: 33277444
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The nuclear receptor TR3 regulates mTORC1 signaling in lung cancer cells expressing wild-type p53.
    Lee SO; Andey T; Jin UH; Kim K; Singh M; Safe S
    Oncogene; 2012 Jul; 31(27):3265-76. PubMed ID: 22081070
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.